A new study has identified at-risk populations for whom depression screening combined with hazardous alcohol use screening could detect depressive symptoms that might otherwise go untreated.

UCSF researchers have discovered how a mutation in a gene regulator called the TERT promoter confers “immortality” on tumor cells, enabling the unchecked cell division that powers their aggressive growth.

A new spinal cord injury protocol, based on research by UCSF scientists, is a mixture of revised evaluations and new treatments to personalize care. It has spurred quicker recoveries for patients.

UCSF researchers have uncovered 12 new anti-CRISPR genes, some of which can inhibit different CRISPR types and could be critical to future gene-editing therapies.

UCSF researchers have shown that it’s possible to study cellular identity by pulverizing brain tissue samples, extracting their RNA in bulk and looking for signature patterns of gene activity.

The availability of biosimilars commonly used to treat moderate to severe RA may not by itself reduce out-of-pocket costs for Medicare beneficiaries due to a lack of manufacturer discounts.

Genetic mutations in a form of non–small cell lung cancer may drive tumor formation by blurring cells’ perception of key growth signals, according to a new laboratory study published Aug. 31, 2018, in Science.

The Resource Allocation Program (RAP), in partnership with many on-campus sources of research funding, facilitates the dissemination, submission, review and award of intramural research funding opportunities on campus.

Researchers at UCSF and the Gladstone Institutes have received an $18 million grant from the National Institutes of Health to launch the Psychiatric Cell Map Initiative.